ClinicalTrials.gov
public full text
Public Domain
ZD 1839 in Treating Patients With Stage IV or Recurrent Kidney Cancer
RATIONALE: Biological therapies such as ZD 1839 may interfere with the growth of the tumor cells and slow the growth of kidney cancer. PURPOSE: Phase II trial to study the effectiveness of ZD 1839 in treating patients who have recurrent or stage IV kidney cancer.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Carboxyamidotriazole in Treating Patients With Advanced Kidney Cancer#902817
- ZD 1839 in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck#1164060
- ZD 1839 in Treating Patients With Glioblastoma Multiforme in First Relapse#856553
- To Evaluate the Efficacy of ZOMETA® in Treatment of Bone Metastases in Patients With Stage IV Nasopharyngeal Cancer#1074736
- ZD 1839 in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer#856821
Record · ID 852955
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive